Newswire (Published: Tuesday, December 12, 2017, Received: Thursday, December 7, 2017, 10:42:13 PM CST)

Word Count: 311

Data on Prostate Cancer Reported by Researchers at Saint Joseph University (The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?)

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating from Beirut, Lebanon, by NewsRx correspondents, research stated, "To determine whether abiraterone acetate or docetaxel should be regarded as the current standard of care for metastatic hormone-naive prostate cancer (mHNPC). A network meta-analysis (NMA) using the frequentist approach and generalized pairwise modeling was computed."

Our news editors obtained a quote from the research from Saint Joseph University, "The results of this NMA favored abiraterone acetate over docetaxel-based regimens (hazard ratio: 0.79; 95% CI: 0.64-0.99) in patients with mHNPC. The results also suggest a reconsideration of the role of prednisone in view of the absence of a survival benefit (hazard ratio: 0.98; 95% CI: 0.59-1.65) with its use."

According to the news editors, the research concluded: "Despite the paucity of direct comparative evidence, the results of this NMA favor the use of abiraterone acetate in the first-line treatment of mHNPC."

For more information on this research see: The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel? Future Oncology, 2017;(): (see also Oncology - Prostate Cancer).

The news editors report that additional information may be obtained by contacting F. Aoun, Dept. of Urology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. Additional authors for this research include E.E. Rassy, G. Sleilaty, T. Assi, Z. Bakouny and J. Kattan.

Keywords for this news article include: Asia, Beirut, Lebanon, Hormones, Oncology, Prostate Cancer, Drugs and Therapies, Prostatic Neoplasms.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


Education and Instruction
      Higher Education


Western Asia


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices